Loading
Women with breast cancer in Brazil's public health system waited a median of 56 days from diagnosis to first treatment, against 34 days for privately insured women, close to the 60-day limit set in law.
A sub-analysis of 1,709 women with stage I to III breast cancer from the AMAZONA III cohort, diagnosed from January 2016 to March 2018 at 22 Brazilian centres, measuring days from diagnosis to first cancer treatment and the factors associated with starting more than 60 days after diagnosis, the limit set by Brazil's Law 12.732 of 2012.
Brazil's 60-day law sets a ceiling, and this is a measurement of how the public system performs against it for one cancer. Knowing where the delay sits is what lets a patient or a health service push on it.
Shares Daniela Dornelles Rosa, AMAZONA III: prospective evaluation of breast cancer at Brazilian institutions (GBECAM 0115), Latin American Cooperative Oncology Group, Carlos Barrios.
Shares Daniela Dornelles Rosa, Latin American Cooperative Oncology Group, Carlos Barrios, HR-positive / HER2-negative breast cancer.
Shares Carlos Barrios, Most of the world has almost no cancer care.
Shares AMAZONA III: prospective evaluation of breast cancer at Brazilian institutions (GBECAM 0115), Latin American Cooperative Oncology Group, HR-positive / HER2-negative breast cancer.
Shares AMAZONA III: prospective evaluation of breast cancer at Brazilian institutions (GBECAM 0115), HR-positive / HER2-negative breast cancer.
Shares Carlos Barrios, Most of the world has almost no cancer care.
Shares Carlos Barrios, Most of the world has almost no cancer care.
Shares Carlos Barrios, HR-positive / HER2-negative breast cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/